EA202192006A1 - HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS - Google Patents

HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS

Info

Publication number
EA202192006A1
EA202192006A1 EA202192006A EA202192006A EA202192006A1 EA 202192006 A1 EA202192006 A1 EA 202192006A1 EA 202192006 A EA202192006 A EA 202192006A EA 202192006 A EA202192006 A EA 202192006A EA 202192006 A1 EA202192006 A1 EA 202192006A1
Authority
EA
Eurasian Patent Office
Prior art keywords
heterocyclic compounds
adenosine antagonists
compounds
adenosine
find
Prior art date
Application number
EA202192006A
Other languages
Russian (ru)
Inventor
Сон Минх Фам
Джякант Канканала
Прадип С. Джадхавар
Бабан Мохан Мулик
Фарха Кхан
Срикант А. Рамачандран
Original Assignee
Ньювейшн Байо Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ньювейшн Байо Инк. filed Critical Ньювейшн Байо Инк.
Priority claimed from PCT/US2020/014206 external-priority patent/WO2020150674A1/en
Publication of EA202192006A1 publication Critical patent/EA202192006A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Представлены соединения аминопиразина в качестве модуляторов аденозинового рецептора. Соединения могут найти применение в качестве терапевтических агентов для лечения заболеваний, опосредованных через сигнальный путь рецептора, сопряженного с G-белком, и могут найти конкретное применение в онкологии.Aminopyrazine compounds are presented as adenosine receptor modulators. The compounds may find use as therapeutic agents for the treatment of diseases mediated through the G-protein coupled receptor signaling pathway and may find particular use in oncology.

EA202192006A 2019-01-23 2020-01-17 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS EA202192006A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962796046P 2019-01-23 2019-01-23
PCT/US2020/014206 WO2020150674A1 (en) 2019-01-18 2020-01-17 Heterocyclic compounds as adenosine antagonists

Publications (1)

Publication Number Publication Date
EA202192006A1 true EA202192006A1 (en) 2021-12-17

Family

ID=80631202

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192006A EA202192006A1 (en) 2019-01-23 2020-01-17 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS

Country Status (1)

Country Link
EA (1) EA202192006A1 (en)

Similar Documents

Publication Publication Date Title
MX2020000690A (en) Heterocyclic compounds as adenosine antagonists.
EA201791239A1 (en) TETRAHYDROPYRIDO [3,4-b] INDOL MODELERS OF ESTROGEN RECEPTORS AND THEIR APPLICATION
CL2021001884A1 (en) Heterocyclic compounds as adenosine antagonists.
NZ737399A (en) Ccr2 modulators
BR112021022576A2 (en) Heteroarylaminopyrimidine amide autophagy inhibitors and methods of using them
EA200971077A1 (en) HETEROCYCLIC KINASE MODULATORS
EA201891656A1 (en) MOLECULES THAT ELECTORALLY ACTIVATE REGULATORY T-CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
CR9891A (en) CICLOPROPIL AMINAS AS H3 HISTAMINE RECEIVER MODULATORS
EA202191852A1 (en) IRREVERSIBLE INHIBITORS OF THE MENIN-MLL INTERACTION
MX2020000693A (en) 1,8-naphthyridinone compounds and uses thereof.
EA200700262A1 (en) ARYLIDENES FOR THE TREATMENT OF DISEASES MEDIATED BY ESTROGEN-RELATED ALPHA RECEPTORS
UY28766A1 (en) ADDITIONAL HETEROPOLYCLIC COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER
CY1114148T1 (en) BRIDGED BICYCLE ARYLS AND BRIDGES
EA201101009A1 (en) ANTAGONISTS C5aR
EA201690502A1 (en) SUBSTITUTED PYRIMIDINE INHIBITORS BMI-1
NI200800314A (en) PYRIDYL AMIDES COMPOUNDS SUBSTITUTED AS MODULATORS OF THE HISTAMINE H3 RECEPTOR
EA201792304A1 (en) COMBINED THERAPY FOR CANCER TREATMENT
NZ736055A (en) Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
EA201791227A1 (en) DOSING MODE OF MAdCAM ANTAGONISTS
BR112021025544A2 (en) Aminopyrimidine amide autophagy inhibitors and methods of using them
CY1123013T1 (en) COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS WITH ACETYLCHOLINESTERASE INHIBITORS
EA202192746A1 (en) HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS
MA32224B1 (en) (Pyrazolyl-carbonyl) imidazolidinone derivatives for the treatment of retroviral diseases
EA201991021A1 (en) COMPOUNDS OF CONDENSED Bicyclic Pyridines AND THEIR APPLICATION AS AMPA RECEPTOR MODULATORS
EA202090270A1 (en) NEW SUBSTITUTED Xanthine Derivatives